SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-014975
Filing Date
2017-08-02
Accepted
2017-08-02 17:31:36
Documents
95
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bmrn-10q_20170630.htm 10-Q 3806371
2 EX-10.1 bmrn-ex101_531.htm EX-10.1 97176
3 EX-31.1 bmrn-ex311_6.htm EX-31.1 16436
4 EX-31.2 bmrn-ex312_8.htm EX-31.2 16504
5 EX-32.1 bmrn-ex321_7.htm EX-32.1 5964
  Complete submission text file 0001564590-17-014975.txt   15164785

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bmrn-20170630.xml EX-101.INS 4445707
7 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20170630.xsd EX-101.SCH 64526
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bmrn-20170630_cal.xml EX-101.CAL 69448
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmrn-20170630_def.xml EX-101.DEF 269341
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20170630_lab.xml EX-101.LAB 488106
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20170630_pre.xml EX-101.PRE 429467
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 171001379
SIC: 2834 Pharmaceutical Preparations